Andrea Ziblat

ORCID: 0000-0003-1469-8836
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Immune Cell Function and Interaction
  • Cancer Immunotherapy and Biomarkers
  • CAR-T cell therapy research
  • Immune cells in cancer
  • Immunotherapy and Immune Responses
  • Reproductive System and Pregnancy
  • IL-33, ST2, and ILC Pathways
  • Immune Response and Inflammation
  • T-cell and B-cell Immunology
  • Dermatology and Skin Diseases
  • Trypanosoma species research and implications
  • Psoriasis: Treatment and Pathogenesis
  • Nicotinic Acetylcholine Receptors Study
  • Antimicrobial Peptides and Activities
  • Cytomegalovirus and herpesvirus research
  • Autoimmune and Inflammatory Disorders Research
  • Cytokine Signaling Pathways and Interactions
  • Vagus Nerve Stimulation Research
  • Research on Leishmaniasis Studies
  • MicroRNA in disease regulation
  • Fibroblast Growth Factor Research
  • Bladder and Urothelial Cancer Treatments
  • Cancer, Stress, Anesthesia, and Immune Response
  • Acute Myeloid Leukemia Research
  • Histone Deacetylase Inhibitors Research

University of Chicago
2021-2025

University of Illinois Chicago
2021-2024

Experimental Medicine and Biology Institute
2011-2022

Consejo Nacional de Investigaciones Científicas y Técnicas
2011-2022

University of Buenos Aires
2014

Abstract Despite the classical function of NK cells in elimination tumor and virus-infected cells, evidence for a regulatory role has been emerging different models autoimmunity, transplantation, viral infections. However, this not fully explored context growing tumor. In article, we show that can limit spontaneous cross-priming Ag-specific CD8+ T leading to reduced memory responses. After challenge with MC57 transduced express model Ag SIY (MC57.SIY), cell–depleted mice exhibited...

10.4049/jimmunol.1502291 article EN The Journal of Immunology 2016-06-25

The cellular source of positive signals that reinvigorate T cells within the tumor microenvironment (TME) for therapeutic efficacy programmed death-1 (PD-1)/programmed death-ligand 1 (PD-L1) blockade has not been clearly defined. We now show Batf3-lineage dendritic (DCs) are essential in this process. Flow cytometric analysis, gene-targeted mice, and blocking antibody studies revealed 4-1BBL is a major co-stimulatory signal provided by these DCs TME translates to CD8

10.1016/j.celrep.2024.114141 article EN cc-by-nc Cell Reports 2024-04-23

IL-27, a member of the IL-12 family cytokines, is produced by APCs, and displays pro- anti-inflammatory effects. How IL-27 affects human NK cells still remains unknown. In this study, we observed that mature DCs secreted blockade IL-27R (CD130) reduced amount IFN-γ during their coculture, showing importance DC-NK-cell crosstalk. Accordingly, rIL-27 stimulated secretion in STAT1-dependent manner, induced upregulation CD25 CD69 on cells, displayed synergistic effect with IL-18. Preincubation...

10.1002/eji.201444699 article EN cc-by European Journal of Immunology 2014-10-12

Abstract NK cells play important roles during immunosurveillance against tumors and viruses as they trigger cytotoxicity susceptible secrete proinflammatory cytokines such IFN-γ. In addition, upon activation, macrophages can become (M1) or anti-inflammatory (M2) cells. Although the consequences of cross-talk between M1 are known, outcome M2 remains ill-defined. Therefore, in current work, we investigated underlying mechanisms interaction resting stimulated human with M2. We observed a lower...

10.4049/jimmunol.1700737 article EN The Journal of Immunology 2017-12-27

ABSTRACT HDACi are being used as a novel, therapeutic approach for leukemias and other hematological malignancies. However, their effect on immune cells remains ill-defined, may impair surveillance. In this work, we demonstrate that TSA, VPA, NaB inhibited IFN-γ production by CD56dim CD56bright NK cell-mediated cytotoxicity against K562 target cells. promoted minor cell apoptosis but nuclear mobilization of NF-κB p50, which was accompanied robust down-regulation NKG2D NKp46 resting NKG2D,...

10.1189/jlb.0711339 article EN Journal of Leukocyte Biology 2011-11-28

Natural Killer (NK) cells play a key role in cancer immunosurveillance. However, NK from patients display an altered phenotype and impaired effector functions. In addition, evidence of regulatory for is emerging diverse models viral infection, transplantation, autoimmunity. Here, we analyzed clear cell renal carcinoma (ccRCC) datasets The Cancer Genome Atlas (TCGA) observed that higher expression signature genes associated with reduced survival. Analysis fresh tumor samples ccRCC unraveled...

10.3389/fimmu.2021.745939 article EN cc-by Frontiers in Immunology 2021-09-20

Based on the notion that hypomorphic germline genetic variants are linked to autoimmune diseases, we reasoned novel targets for cancer immunotherapy might be identified through associated with greater T-cell infiltration into tumors. Here, report while investigating polymorphisms a tumor immune gene signature, PKCδ as candidate. Genetic deletion of in mice resulted improved endogenous antitumor immunity and increased efficacy anti-PD-L1. Single-cell RNA sequencing revealed myeloid cell...

10.1158/2326-6066.cir-23-0999 article EN Cancer Immunology Research 2025-01-14

<div>Abstract<p>Based on the notion that hypomorphic germline genetic variants are linked to autoimmune diseases, we reasoned novel targets for cancer immunotherapy might be identified through associated with greater T-cell infiltration into tumors. Here, report while investigating polymorphisms a tumor immune gene signature, protein kinase C delta (PKCδ) as candidate. Genetic deletion of <i>Prkcd</i> in mice resulted improved endogenous antitumor immunity and...

10.1158/2326-6066.c.7749848 preprint EN 2025-04-02

<p>Hematopoietic loss of PKCδ via Vav1-iCre delays tumor growth and alters inflammatory gene expression in alternative “2C1”Prkcdfl/fl founder.</p>

10.1158/2326-6066.28713791 preprint EN 2025-04-02

<p>Hematopoietic loss of PKCδ via Vav1-iCre delays tumor growth and alters inflammatory gene expression in “2B4”Prkcdfl/fl founder.</p>

10.1158/2326-6066.28713797 preprint EN 2025-04-02

<p>Loss of PKCδ in myeloid cells delays tumor growth and is further delayed with anti-PD-L1 therapy multiple Prkcdfl/fl founders.</p>

10.1158/2326-6066.28713788 preprint EN 2025-04-02
Coming Soon ...